Therefore, to better understand how genetic variation in this locus may modify the severity of CF lung disease, we directly assessed whether BPIFA1 and BPIFB1 inhibited growth of P. aeruginosa—the most clinically relevant CF pathogen. Here, BPIFA1 is linked to cystic fibrosis.